177 related articles for article (PubMed ID: 27753514)
1. Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool.
Chatterjee M; Gawaz M
Platelets; 2017 Jun; 28(4):362-371. PubMed ID: 27753514
[TBL] [Abstract][Full Text] [Related]
2. Implications of glycoprotein VI for theranostics.
Gawaz M; Vogel S; Pfannenberg C; Pichler B; Langer H; Bigalke B
Thromb Haemost; 2014 Jul; 112(1):26-31. PubMed ID: 24553806
[TBL] [Abstract][Full Text] [Related]
3. GPVI modulation during platelet activation and storage: its expression levels and ectodomain shedding compared to markers of platelet storage lesion.
Hosseini E; Ghasemzadeh M; Nassaji F; Jamaat ZP
Platelets; 2017 Jul; 28(5):498-508. PubMed ID: 27778530
[TBL] [Abstract][Full Text] [Related]
4. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases.
Bender M; Hofmann S; Stegner D; Chalaris A; Bösl M; Braun A; Scheller J; Rose-John S; Nieswandt B
Blood; 2010 Oct; 116(17):3347-55. PubMed ID: 20644114
[TBL] [Abstract][Full Text] [Related]
5. Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI.
Wijeyewickrema LC; Gardiner EE; Moroi M; Berndt MC; Andrews RK
Thromb Haemost; 2007 Dec; 98(6):1285-90. PubMed ID: 18064326
[TBL] [Abstract][Full Text] [Related]
6. Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches.
Vélez P; Ocaranza-Sánchez R; López-Otero D; Grigorian-Shamagian L; Rosa I; Guitián E; García-Acuña JM; González-Juanatey JR; García Á
Sci Rep; 2016 Dec; 6():39603. PubMed ID: 28004756
[TBL] [Abstract][Full Text] [Related]
7. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa.
Al-Tamimi M; Grigoriadis G; Tran H; Paul E; Servadei P; Berndt MC; Gardiner EE; Andrews RK
Blood; 2011 Apr; 117(14):3912-20. PubMed ID: 21252089
[TBL] [Abstract][Full Text] [Related]
8. Focusing on plasma glycoprotein VI.
Al-Tamimi M; Arthur JF; Gardiner E; Andrews RK
Thromb Haemost; 2012 Apr; 107(4):648-55. PubMed ID: 22274761
[TBL] [Abstract][Full Text] [Related]
9. Fibrin exposure triggers αIIbβ3-independent platelet aggregate formation, ADAM10 activity and glycoprotein VI shedding in a charge-dependent manner.
Montague SJ; Hicks SM; Lee CS; Coupland LA; Parish CR; Lee WM; Andrews RK; Gardiner EE
J Thromb Haemost; 2020 Jun; 18(6):1447-1458. PubMed ID: 32198957
[TBL] [Abstract][Full Text] [Related]
10. Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity.
Loyau S; Dumont B; Ollivier V; Boulaftali Y; Feldman L; Ajzenberg N; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):778-85. PubMed ID: 22155453
[TBL] [Abstract][Full Text] [Related]
11. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
[TBL] [Abstract][Full Text] [Related]
12. Platelets in atherothrombosis--diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases.
Bigalke B; Schuster A; Sopova K; Wurster T; Stellos K
Curr Vasc Pharmacol; 2012 Sep; 10(5):589-96. PubMed ID: 22338574
[TBL] [Abstract][Full Text] [Related]
13. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS).
Bigalke B; Stellos K; Weig HJ; Geisler T; Seizer P; Kremmer E; Pötz O; Joos T; May AE; Lindemann S; Gawaz M
Basic Res Cardiol; 2009 May; 104(3):352-7. PubMed ID: 19190951
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive imaging of glycoprotein VI binding to injured arterial lesions.
Gawaz M; Konrad I; Hauser AI; Sauer S; Li Z; Wester HJ; Bengel FM; Schwaiger M; Schömig A; Massberg S; Haubner R
Thromb Haemost; 2005 May; 93(5):910-3. PubMed ID: 15886808
[TBL] [Abstract][Full Text] [Related]
15. Platelet GPVI: a target for antithrombotic therapy?!
Dütting S; Bender M; Nieswandt B
Trends Pharmacol Sci; 2012 Nov; 33(11):583-90. PubMed ID: 22901552
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitors of metalloproteinases (TIMPs) modulate platelet ADAM10 activity.
Lee CSM; Kaur A; Montague SJ; Hicks SM; Andrews RK; Gardiner EE
Platelets; 2023 Dec; 34(1):2288213. PubMed ID: 38031964
[TBL] [Abstract][Full Text] [Related]
17. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein VI - novel target in antiplatelet medication.
Borst O; Gawaz M
Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
[TBL] [Abstract][Full Text] [Related]
19. GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding.
Bergmeier W; Rabie T; Strehl A; Piffath CL; Prostredna M; Wagner DD; Nieswandt B
Thromb Haemost; 2004 May; 91(5):951-8. PubMed ID: 15116256
[TBL] [Abstract][Full Text] [Related]
20. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome.
Bigalke B; Lindemann S; Ehlers R; Seizer P; Daub K; Langer H; Schonberger T; Kremmer E; Siegel-Axel D; May AE; Gawaz M
Eur Heart J; 2006 Sep; 27(18):2165-9. PubMed ID: 16923742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
